Targeting the mTOR Signaling Network for Cancer TherapyMERIC-BERNSTAM, Funda; GONZALEZ-ANGULO, Ana Maria.Journal of clinical oncology. 2009, Vol 27, Num 13, pp 2278-2287, issn 0732-183X, 10 p.Article

Future of Personalized Medicine in Oncology: A Systems Biology ApproachGONZALEZ-ANGULO, Ana Maria; HENNESSY, Bryan T. J; MILLS, Gordon B et al.Journal of clinical oncology. 2010, Vol 28, Num 16, pp 2777-2783, issn 0732-183X, 7 p.Article

Multimodality Imaging of Triple Receptor-Negative Tumors With Mammography, Ultrasound, and MRIDOGAN, Basak E; GONZALEZ-ANGULO, Ana Maria; GILCREASE, Michael et al.American journal of roentgenology (1976). 2010, Vol 194, Num 4, pp 1160-1166, issn 0361-803X, 7 p.Article

Somatic Mutations in BRCA1 and BRCA2 Could Expand the Number of Patients That Benefit From Poly (ADP Ribose) Polymerase Inhibitors in Ovarian CancerHENNESSY, Bryan T. J; TIMMS, Kirsten M; YANG LI et al.Journal of clinical oncology. 2010, Vol 28, Num 22, pp 3570-3576, issn 0732-183X, 7 p.Article

Pharmacodynamic Markers of Perifosine EfficacyHENNESSY, Bryan T; YILING LU; HENDERSON, I. Craig et al.Clinical cancer research. 2007, Vol 13, Num 24, pp 7421-7431, issn 1078-0432, 11 p.Article

Emergence of Constitutively Active Estrogen Receptor-α Mutations in Pretreated Advanced Estrogen Receptor-Positive Breast CancerJESELSOHN, Rinath; YELENSKY, Roman; ARTEAGA, Carlos L et al.Clinical cancer research (Print). 2014, Vol 20, Num 7, pp 1757-1767, issn 1078-0432, 11 p.Article

A Phase 1 Study of Weekly Everolimus (RAD001) in Combination With Docetaxel in Patients With Metastatic Breast CancerMOULDER, Stacy; GLADISH, Gregory; RIVERA, Edgardo et al.Cancer. 2012, Vol 118, Num 9, pp 2378-2384, issn 0008-543X, 7 p.Article

Bisphosphonates and Pathologic Complete Response to Taxane- and Anthracycline-Based Neoadjuvant Chemotherapy in Patients With Breast CancerCHAVEZ-MACGREGOR, Mariana; BROWN, Erika; XIUDONG LEI et al.Cancer. 2012, Vol 118, Num 2, pp 326-332, issn 0008-543X, 7 p.Article

A Kinome-Wide Screen Identifies the Insulin/IGF-I Receptor Pathway as a Mechanism of Escape from Hormone Dependence in Breast CancerFOX, Emily M; MILLER, Todd W; SHYR, Yu et al.Cancer research (Chicago, Ill.). 2011, Vol 71, Num 21, pp 6773-6784, issn 0008-5472, 12 p.Article

Differential Response to Neoadjuvant Chemotherapy Among 7 Triple-Negative Breast Cancer Molecular SubtypesMASUDA, Hiroko; BAGGERLY, Keith A; FRASER SYMMANS, W et al.Clinical cancer research (Print). 2013, Vol 19, Num 19, pp 5533-5540, issn 1078-0432, 8 p.Article

PIK3CA/PTEN Mutations and Akt Activation As Markers of Sensitivity to Allosteric mTOR InhibitorsMERIC-BERNSTAM, Funda; AKCAKANAT, Argun; PHAN, Alexandria T et al.Clinical cancer research (Print). 2012, Vol 18, Num 6, pp 1777-1789, issn 1078-0432, 13 p.Article

Nodal Status and Clinical Outcomes in a Large Cohort of Patients With Triple-Negative Breast CancerHERNANDEZ-AYA, Leonel F; CHAVEZ-MACGREGOR, Mariana; GONZALEZ-ANGULO, Ana Maria et al.Journal of clinical oncology. 2011, Vol 29, Num 19, pp 2628-2634, issn 0732-183X, 7 p.Article

Triple Receptor-Negative Breast Cancer : The Effect of Race on Response to Primary Systemic Treatment and Survival OutcomesDAWOOD, Shaheenah; BROGLIO, Kristine; HORTOBAGYI, Gabriel N et al.Journal of clinical oncology. 2009, Vol 27, Num 2, pp 220-226, issn 0732-183X, 7 p.Article

Influence of Biospecimen Variables on Proteomic Biomarkers in Breast CancerMERIC-BERNSTAM, Funda; AKCAKANAT, Argun; MITTENDORF, Elizabeth et al.Clinical cancer research (Print). 2014, Vol 20, Num 14, pp 3870-3883, issn 1078-0432, 14 p.Article

Biomarkers of Response to Akt Inhibitor MK-2206 in Breast CancerSANGAI, Takafumi; AKCAKANAT, Argun; MERIC-BERNSTAM, Funda et al.Clinical cancer research (Print). 2012, Vol 18, Num 20, pp 5816-5828, issn 1078-0432, 13 p.Article

Differences in Survival Among Women With Stage III Inflammatory and Noninflammatory Locally Advanced Breast Cancer Appear Early: A Large Population-Based StudyDAWOOD, Shaheenah; UENO, Naoto T; VALERO, Vicente et al.Cancer. 2011, Vol 117, Num 9, pp 1819-1826, issn 0008-543X, 8 p.Article

Trastuzumab Has Preferential Activity against Breast Cancers Driven by HER2 HomodimersGHOSH, Ritwik; NARASANNA, Archana; SPERINDE, Jeff et al.Cancer research (Chicago, Ill.). 2011, Vol 71, Num 5, pp 1871-1882, issn 0008-5472, 12 p.Article

Triple-Negative Breast Cancer in Hispanic Patients: High Prevalence, Poor Prognosis, and Association With Menopausal Status, Body Mass IndexLARA-MEDINA, Fernando; PEREZ-SANCHEZ, Victor; MOHAR, Alejandro et al.Cancer. 2011, Vol 117, Num 16, pp 3658-3669, issn 0008-543X, 12 p.Article

Disease-free and overall survival after pathologic complete disease remission of cytologically proven inflammatory breast carcinoma axillary lymph node metastases after primary systemic chemotherapyHENNESSY, Bryan T; GONZALEZ-ANGULO, Ana Maria; VALERO, Vicente et al.Cancer. 2006, Vol 106, Num 5, pp 1000-1006, issn 0008-543X, 7 p.Article

Integrative Analysis of Cyclin Protein Levels Identifies Cyclin B1 as a Classifier and Predictor of Outcomes in Breast CancerAGARWAL, Roshan; GONZALEZ-ANGULO, Ana-Maria; WEN LIN KUO et al.Clinical cancer research (Print). 2009, Vol 15, Num 11, pp 3654-3662, issn 1078-0432, 9 p.Article

Characterization of a Naturally Occurring Breast Cancer Subset Enriched in Epithelial-to-Mesenchymal Transition and Stem Cell CharacteristicsHENNESSY, Bryan T; GONZALEZ-ANGULO, Ana-Maria; WENBIN LIU et al.Cancer research (Chicago, Ill.). 2009, Vol 69, Num 10, pp 4116-4124, issn 0008-5472, 9 p.Article